News
Das Implantat der Zukunft | Handelszeitung
www.handelszeitung.ch
... gesammelt hat, bringen COO und Life-Science-Experte Boris Warnack sowie Eliane Schutte, Chief Development Officer, Know-how in die Geschäftsleitung.
Xeltis extends series B financing to €30 million - Cardiovascular News
cardiovascularnews.com
... and its Executive Team has been joined by international life science professionals, including COO Boris Warnack and CDO Eliane Schutte.
Xeltis acquires additional €3M in series B financing
www.startupticker.ch
... including COO Boris Warnack and CDO Eliane Schutte. “Xeltis is one of the most innovative and fast-paced companies I have come across in ...
www.tctmd.com › news › big-questions-bioresor...Big Questions for Bioresorbable Scaffolds: Experts and ...
www.tctmd.com
Boris Warnack, PhD (Xeltis, Zurich, Switzerland), on the other hand, argued there will always be mechanical property differences between ...
sortiert nach Relevanz / Datum